FDA Issues ROSZET® Statements Letter to Althera Pharmaceuticals
The FDA-approved product labeling (PI) for Roszet includes myopathy, proteinuria and hematuria, and increases in HbA1c and fasting serum glucose levels.
Source: natlawreview.com
Clinical Studies Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clinical Studies Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clinical Studies Section Today - Breaking & Trending Today